Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.06739 | 83 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.0601 | 83 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.9919 | 82 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.99086 | 81 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.89672 | 81 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.73346 | 82 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.8751 | 83 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.04182 | 83 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.91833 | 82 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.14684 | 83 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.5526 | 86 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.28531 | 84 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.50767 | 86 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.25355 | 84 |